Medisafe Project iOS and Android/Free    A unique free medication reminder uses cloud sync technology to send alerts to users’ family, friends, and caretakers when they miss a dose. The MediSafe Project 2.0 color codes adherence rates as a quick way for users to gauge their adherence to medications as prescribed. …

CardeaScreen  A new portable highly accurate screening device helps to screen for heart problems in young athletes. Young athletes can be at risk of sudden cardiac arrest because of unrecognized congenital heart defects, but now a handheld device may help identify those at risk. The handheld CardeaScreen wirelessly connects to …

FDA Approves Johnson & Johnson’s First In Class SGLT-2 Inhibitor diabetes drug, canagliflozin (Invokana). See this week’s Item #1. J&J Recalls 2 Million Blood Glucose Meters. See this week’s Item #5. 

A recent study shows Mexican-Americans being treated for diabetes are two times more likely to develop dementia and memory loss than their peers without diabetes. While the trend was more pronounced among Mexican-Americans who were receiving medical treatment, the trend was also present among those who were untreated. The findings …

A breath test profile of microorganisms inhabiting the gut may be able to tell doctors how susceptible a person is to developing obesity. The study shows that people whose breath has high concentrations of both hydrogen and methane gasses are more likely to have a higher BMI and percentage of …

One impact of the obesity epidemic is that people are now too fat to ride horses. A third of recreational riders are too heavy for their beasts of burden, and are giving the animals health problems including lameness and back pain. The rotundness of their riders may also be leading …

Johnson & Johnson’s SGLT2 canagliflozin (Invokana) has just received FDA approval, while Boehringer Ingelheim and Eli Lilly submit their SGLT2 inhibitor (empagliflozin) to the FDA…. U.S. health regulators have approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. …

A community-based diabetes-prevention program produced significant reductions in blood glucose and body mass index (BMI) among individuals with prediabetes, while also reducing costs at 2 years….

Insulin tablets’ safety, tolerability, exposure, and effect on blood glucose levels were tested in a clinical trial….

In an animal study, high-carbohydrate intake after birth led to detrimental long-term effects….